- $783.21bn
- $843.22bn
- $35.82bn
2019 November 3rd | 2020 November 1st | 2021 October 31st | 2022 October 30th | 2023 October 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 22,597 | 23,888 | 27,450 | 33,203 | 35,819 |
Cost of Revenue | |||||
Gross Profit | 12,560 | 13,551 | 16,861 | 22,100 | 24,694 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 19,153 | 19,702 | 18,931 | 18,978 | 19,612 |
Operating Profit | 3,444 | 4,186 | 8,519 | 14,225 | 16,207 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,226 | 2,443 | 6,765 | 12,434 | 15,097 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,736 | 2,961 | 6,736 | 11,495 | 14,082 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,724 | 2,960 | 6,736 | 11,495 | 14,082 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,695 | 2,663 | 6,437 | 11,223 | 14,082 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.772 | 0.659 | 1.54 | 2.67 | 3.35 |
Dividends per Share |